These are the fastest-growing biotech companies

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

• We found the 29 fastest-growing biotechs;
• Sanofi and GSK get promising results for their COVID-19 shot;
• Amazon is launching a diagnostics brand, Insider has learned.

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...

See the 29 fastest-growing biotech companies, which hired hundreds of new workers in 2020 and grew by at least 50%

• Insider analyzed more than 150 drug companies to figure out which biotechs grew the most in 2020.
• 29 biotech and pharma companies expanded their head count by at least 50% during the pandemic.
• Several of the companies told us they intend to continue hiring throughout 2021.

Find the full list here>>

Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot

• Sanofi and GlaxoSmithKline said that their experimental COVID-19 vaccine succeeded in a mid-stage trial.
• The pharma giants plan to launch a pivotal-stage study with 35,000 volunteers in the coming weeks.
• The shot suffered from disappointing data and delays in 2020.

The companies now hope for approval by year's end>>

Amazon plans new 'Diagnostics' brand that offers at-home medical tests for COVID-19, sexually transmitted infections, and clinical genomics

• Amazon is planning to launch a new brand called "Diagnostics," Insider has learned.
• The team is in talks to offer home testing kits for COVID-19 and other infections, including STDs.
• It's part of Amazon's move into the broader healthcare space. It also operates an online pharmacy and telehealth services.

Get the scoop>>

More stories we're reading:

• Coronavirus vaccines are more extraordinary in the real world than in trials - even in the face of variants (Insider)
• The US is sharing 20 million authorized vaccines abroad by the end of June (Bloomberg)
• A new Medicare program promises to be a 'huge' revenue opportunity for companies like Clover Health, but profiting from it won't be easy (Insider)
• Why you might have a pushy dentist (US News)
• The US is studying how COVID-19 vaccines work in people with suppressed immune systems - after research suggested they develop fewer antibodies from the shots (Insider)

- Lydia